Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of May 2019, specifically dated May 20, 2019. The registrant is a foreign private issuer based in Petach-Tikva, Israel, and files annual reports on Form 20-F.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels for a specific reporting period. The primary financial data point disclosed is a capital raise event.
- Capital Raise: The company entered into a definitive agreement to receive gross proceeds of approximately $6,000,000.
- Investors: The proceeds are from certain institutional investors.
Material Changes
The filing does not provide comparative financial data against a prior period to assess material changes in operating metrics. The significant event reported is the execution of the definitive agreement for the $6,000,000 capital raise.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies beyond the announcement of the financing agreement. The press release detailing the transaction is incorporated by reference as Exhibit 99.1.
Investor Verification Checklist
- Verify the final closing date and actual amount of the $6,000,000 capital raise.
- Review the attached press release (Exhibit 99.1) for details on the terms of the agreement with institutional investors.
- Confirm the intended use of proceeds for the raised capital.
- Check subsequent filings for any dilution impact on existing shareholders.